Melanoma and Skin Cancer Trials - MASC Trials

Melanoma and Skin Cancer Trials - MASC Trials Conquering melanoma and skin cancer through clinical trials We aim to make our clinical trials accessible to all Australians, no matter where they live.

Melanoma and Skin Cancer Trials (MASC Trials) specialises in investigator-initiated melanoma and skin cancer research. We work collaboratively with world-leading researchers to deliver clinical trials that improve melanoma and skin cancer outcomes. Since 1999, the high-quality evidence published from our trials has changed clinical practice to impact the lives of patients and improve how doctors prevent, diagnose and treat melanoma and skin cancer. Our network of over 2,250 healthcare professionals and consumers spans all Australian metropolitan cities and many regional towns, with trials currently running at 111 institutions around the world. To learn about our research, including clinical trials that are currently enrolling participants, visit our website: https://www.masc.org.au/

👁️ Videos of the 2025 Australasian Ocular Melanoma Alliance (AOMA) Virtual Summit held on Saturday 8 November are now av...
05/12/2025

👁️ Videos of the 2025 Australasian Ocular Melanoma Alliance (AOMA) Virtual Summit held on Saturday 8 November are now available online. Watch available sessions from ocular melanoma experts and consumers.
🔗 https://www.masc.org.au/aoma-summit-2025/

02/12/2025

🚨 New Publication Alert! 🚨
We are excited to announce that results from the EAGLE FM trial on the accuracy of using PET/CT imaging for diagnosing pelvic lymph node metastases in melanoma patients with groin lymph node involvement have been published in the European Journal of Surgical Oncology.
https://www.ejso.com/article/S0748-7983(25)01591-4/abstract

✅ What is EAGLE FM?
• An international phase III randomised trial across 17 sites in 6 countries
• Sponsored by MASC Trials, led by Prof Andrew Spillane
• Enrolled 101 patients with stage III melanoma with confirmed melanoma spread to the superficial area of the groin
• PET/CT imaging had to be negative for pelvic lymph node involvement to be eligible for randomisation

The trial compared two commonly performed surgical methods: A limited superficial lymph node area removal, compared to that superficial procedure in combination with more complex deeper pelvic lymph node removal. The decision between these options was previously controversial in patients with this common pattern of disease spread. The study aimed to determine which method is safest for patients in terms of melanoma survival, quality of life, and side effects of the surgery.

🔍 Key Finding:
In this substudy, data on PET/CT's accuracy for diagnosing pelvic lymph node metastases showed that whilst PET/CT remains important for staging advanced melanoma patients to rule out disease spread elsewhere, compared to microscopic assessment, it has limited accuracy for pelvic lymph node assessment.

👏Huge congratulations to Dr Mike Russell for leading this analysis and publication!

📢 Coming soon: The main trial results with 5-year follow-up data—stay tuned!

📢 Together, we’re driving change for melanoma and skin cancer in Australia!Yesterday, our CEO Gabrielle Byars and Clinic...
27/11/2025

📢 Together, we’re driving change for melanoma and skin cancer in Australia!

Yesterday, our CEO Gabrielle Byars and Clinical Program Lead Katja Loewe joined clinicians, researchers, and industry partners including and , along with advocates at Parliament House to keep skin cancer firmly on the national agenda.

It was fantastic catching up with Australian Melanoma and Skin Cancer Alliance (AMSCA) members at the Parliamentary Friends of Melanoma & Skin Cancer Awareness Start of Summer BBQ Lunch.

Later, Gabrielle attended MSCAN’s first Thought Leadership Roundtable, bringing together people with lived experience, clinicians, researchers, organisations, and partners to collaborate on solutions.

👏 Congratulations to MSCAN and ACD – The Australasian College of Dermatologists – on launching the National Skin Cancer Scorecard 2025!

✅ The Scorecard shows how Australia is tracking in prevention, early detection, treatment, support & care, with 16 evidence-based measures highlighting gaps and next steps to reduce the burden of melanoma and skin cancer.

Skin cancer is Australia’s most common cancer, taking more than 2,000 lives every year and costing the health system $2.47 billion annually. We can change this—but only if we act together.

👉 Explore the Scorecard and join us in keeping skin cancer on the national agenda:
🔗 https://lnkd.in/g43j8YQP

🌞 Start of Summer BBQ at Parliament House 🌞Today we joined the melanoma and skin cancer community, clinicians, researche...
26/11/2025

🌞 Start of Summer BBQ at Parliament House 🌞

Today we joined the melanoma and skin cancer community, clinicians, researchers, industry leaders, and advocates for the Parliamentary Friends of Melanoma & Skin Cancer Awareness Start of Summer BBQ Lunch.

A huge thank you to the Melanoma & Skin Cancer Advocacy Network (MSCAN) and Co-Chairs The Hon. Jason Clare MP and The Hon. Darren Chester MP for leading this important initiative. We’re grateful for the opportunity to engage with members of the Australasian Melanoma and Skin Cancer Alliance (AMSCA) as we work together to improve prevention, early detection, and treatment outcomes for Australians affected by these cancers.

Summer is here—let’s keep raising awareness because early detection saves lives!

Skin cancer is Australia’s most common, most costly, and one of our most preventable cancers. Two in three Australians w...
19/11/2025

Skin cancer is Australia’s most common, most costly, and one of our most preventable cancers. Two in three Australians will be diagnosed with skin cancer in their lifetime, yet research shows that young Australians are less inclined to protect themselves during outdoor activities.

The good news? It’s almost entirely preventable by using the five forms of sun protection:
✅ Slip into sun-protective clothing
✅ Slop on SPF50+ sunscreen
✅ Slap on a broad-brimmed hat
✅ Seek shade
✅ Slide on sunglasses

Make sure to protect yourself whenever the UV is 3 and above ☀️

Missed the sessions? Don’t panic! Videos of the 2025 Australasian Ocular Melanoma Alliance (AOMA) Virtual Summit held on...
19/11/2025

Missed the sessions? Don’t panic! Videos of the 2025 Australasian Ocular Melanoma Alliance (AOMA) Virtual Summit held on Saturday 8 November are coming soon.

We wrapped up an impactful day in Wellington at the New Zealand Skin Cancer Prevention and Early Detection parliamentary...
11/11/2025

We wrapped up an impactful day in Wellington at the New Zealand Skin Cancer Prevention and Early Detection parliamentary event. It was a privilege to meet Deputy Prime Minister David Seymour, Health Minister Simeon Brown, MP Todd Stephenson, MP Sam Uffindel, who shared a personal connection to melanoma, and Hon Peeni Henare MP.

We were joined by incredible advocates and experts, including Dr Bronwen McNoe (University of Otago), Racheal Neumann (Cancer Society NZ), Andrea Newland (Melanoma New Zealand), Katrina Patterson, and Dr Susan Seifried (Skin Cancer New Zealand).
Special thanks to Dr Dirk Venter for opening the event and Victoria Beedle for organising on behalf of the Skin Cancer College Australasia.

Together, we’re driving awareness and calling for greater investment in prevention and early detection to tackle one of New Zealand’s most pressing health challenges.

🌞 This morning in Wellington | Honoured to attend the New Zealand Skin Cancer Prevention and Early Detection parliamenta...
10/11/2025

🌞 This morning in Wellington | Honoured to attend the New Zealand Skin Cancer Prevention and Early Detection parliamentary event, hosted by the Skin Cancer College Australasia.

With New Zealand’s high incidence of skin cancer, today’s gathering is a vital opportunity to connect with our New Zealand colleagues and parliamentarians — to raise awareness, strengthen prevention and early detection strategies, and explore new research opportunities that can drive meaningful change.

Looking forward to insightful conversations and collaborative action.

🎉 Thank you to Ideaya Biosciences for your valued support as Gold Sponsor of the 2025 AOMA Virtual Summit.Your partnersh...
10/11/2025

🎉 Thank you to Ideaya Biosciences for your valued support as Gold Sponsor of the 2025 AOMA Virtual Summit.

Your partnership helped deliver a truly collaborative event—bringing together clinicians, researchers, patients, and consumers to advance ocular melanoma care and research.

🎓 Missed the live event? Register now for early access to session recordings:

🔗 https://www.masc.org.au/aoma-summit-2025/

🎉 Thank you, Medison Pharma Australia!We’re incredibly grateful for your generous support as Platinum Sponsor of the 202...
10/11/2025

🎉 Thank you, Medison Pharma Australia!

We’re incredibly grateful for your generous support as Platinum Sponsor of the 2025 Australasian Ocular Melanoma Alliance (AOMA) Virtual Summit, held on Saturday 8 November.

Thanks to your contribution, the summit was a great success—bringing together clinicians, researchers, and advocates to advance ocular melanoma care and research.

📚 CPD accredited by Optometry Australia and the Optometrists and Dispensing Opticians Board, New Zealand

🎓 If you couldn’t attend the live meeting, we still encourage you to register to gain early access to the session videos.

🔗 Register for free: https://www.masc.org.au/aoma-summit-2025/

Don’t forget to join us at the 2025 AOMA Virtual Summit tomorrow!Visit the AOMA Virtual Summit website for the program a...
07/11/2025

Don’t forget to join us at the 2025 AOMA Virtual Summit tomorrow!

Visit the AOMA Virtual Summit website for the program and to learn about the speakers. You can watch from anywhere in the world, and if you can’t watch the event live, then register for early access to the session videos.

📅 Saturday, 8 November

Register now: https://www.masc.org.au/aoma-summit-2025/

This event has Continuing Professional Development (CPD) accreditation from:
👁️ Optometry Australia https://www.optometry.org.au/institute-of-excellence/cpd-events/2025-australasian-ocular-melanoma-alliance-aoma-virtual-summit/
👁️ Optometrists and Dispensing Opticians Board https://odob.health.nz/site/events and search for the event name ‘AOMA’. Please email your ODOB registration number to hello@masc.org.au.

Address

553 St Kilda Road
Melbourne, VIC
3004

Opening Hours

Monday 9am - 5pm
Tuesday 9am - 5pm
Wednesday 9am - 5pm
Thursday 9am - 5pm
Friday 9am - 5pm

Telephone

+61399039022

Alerts

Be the first to know and let us send you an email when Melanoma and Skin Cancer Trials - MASC Trials posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram